Three EPFL-born startups receive key funding to advance breakthrough technologies in health and biology.

Reverso Therapeutics, a University of Geneva (UNIGE) pharmaceutical spin-off, and winner of the Bioinnovation Day Best Academic Project Award 2025, has been awarded a CHF 710,000 grant from Innosuisse to accelerate the development of its breakthrough reversible anticoagulant technology.

The Jura-based medtech startup Altiscreen has obtained CHF 150,000 from Venture Kick to build a portable drug-testing solution that delivers…

Two Tech Seed loans of CHF 100,000 each were awarded by FIT to Databaum , an artificial intelligence platform for…

Two projects from the University of Geneva and one project from CERN have each been awarded CHF 50,000 in funding…

Bio-Techne (formerly Lunaphore) has announced a strategic partnership between its spatial biology brand Lunaphore and the Wyss Center Geneva to…

DigeHealth SA, a Swiss medtech company developing a wearable device that “listens to the gut” to support early detection and…

Led by Isa Dupont, a nurse, and Gaspard Chevassus, an engineer, the StudentsPool project is reinventing ad hoc recruitment and…

EspeRare, a pioneering Geneva-based nonprofit biotech, announced that it has been awarded a Grand Challenges grant from the Gates Foundation….

Testmate Health and Intermountain Health have announced a strategic partnership and investment to accelerate access to rapid, low-cost molecular tests…

The clinic group is soon to be acquired by the Geneva-based shipping giant. The restructuring is expected to be completed by the end of 2026.

This new center is designed to accelerate the development of neuromodulation technologies for psychiatric and neurological disorders.